Virus Mediated Diseases
There remains a strong demand for safe and effective therapies to treat viral infections. The company is committed to developing and commercializing antiviral products for treating and even preventing viral infections in humans and animals, both domesticated and commercial livestock. Nerium oleander-based therapy represents a new safe approach to prevention as well as treatment of virus mediated disease in humans and animals.
Our products and a key ingredient, oleandrin, have now been shown to act in both a prophylactic as well as therapeutic manner against a wide variety of enveloped viruses. Data demonstrate that our products are effective at inhibiting viral replication within infected cells and at damaging viral progeny. The virus particles that are produced are ‘damaged’ and far less infective making them targets for our own human immune system.
We and our investors strongly believe in the potential benefits that our products might offer toward meeting the global needs. We strongly believe in the immediate socioeconomic impact our products can have in fighting virus mediated diseases and are aggressively pursuing their regulatory approval and commercialization for antiviral therapies in humans and animals.